HK1060883A1 - Chemical compounds. - Google Patents
Chemical compounds.Info
- Publication number
- HK1060883A1 HK1060883A1 HK04103858A HK04103858A HK1060883A1 HK 1060883 A1 HK1060883 A1 HK 1060883A1 HK 04103858 A HK04103858 A HK 04103858A HK 04103858 A HK04103858 A HK 04103858A HK 1060883 A1 HK1060883 A1 HK 1060883A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- chemical compounds
- formula
- compounds
- present
- beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- External Artificial Organs (AREA)
- Mechanical Coupling Of Light Guides (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0102408.2A GB0102408D0 (en) | 2001-01-31 | 2001-01-31 | Chemical compounds |
| PCT/US2001/049299 WO2002060885A1 (en) | 2001-01-31 | 2001-12-17 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1060883A1 true HK1060883A1 (en) | 2004-08-27 |
Family
ID=9907834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK04103858A HK1060883A1 (en) | 2001-01-31 | 2004-05-28 | Chemical compounds. |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1366033B1 (xx) |
| JP (1) | JP2004521895A (xx) |
| KR (1) | KR20030070923A (xx) |
| CN (1) | CN1487928A (xx) |
| AT (1) | ATE294167T1 (xx) |
| AU (1) | AU2002246720B2 (xx) |
| BR (1) | BR0116854A (xx) |
| CA (1) | CA2434853A1 (xx) |
| CZ (1) | CZ20032085A3 (xx) |
| DE (1) | DE60110468T2 (xx) |
| DK (1) | DK1366033T3 (xx) |
| ES (1) | ES2240557T3 (xx) |
| GB (1) | GB0102408D0 (xx) |
| HK (1) | HK1060883A1 (xx) |
| HU (1) | HUP0303026A3 (xx) |
| IL (2) | IL156639A0 (xx) |
| MX (1) | MXPA03006847A (xx) |
| NO (1) | NO20033401L (xx) |
| NZ (1) | NZ526846A (xx) |
| PL (1) | PL363359A1 (xx) |
| PT (1) | PT1366033E (xx) |
| WO (1) | WO2002060885A1 (xx) |
| ZA (1) | ZA200305770B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0102407D0 (en) | 2001-01-31 | 2001-03-14 | Glaxo Group Ltd | Process |
| US7709677B2 (en) | 2001-01-31 | 2010-05-04 | Glaxosmithkline Llc | Process of preparing arylethanoldiamines |
| EP1424079A1 (en) * | 2002-11-27 | 2004-06-02 | Boehringer Ingelheim International GmbH | Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9207964D0 (en) * | 1992-04-10 | 1992-05-27 | Ici Plc | Chemical compounds |
| WO1995033724A1 (en) * | 1994-06-09 | 1995-12-14 | Glaxo Group Limited | Phenethanolamine derivatives and their use as atypical beta-adrenoceptor agonists |
| GB9525177D0 (en) * | 1995-12-08 | 1996-02-07 | Glaxo Group Ltd | Chemical compounds |
| GB9812709D0 (en) * | 1998-06-13 | 1998-08-12 | Glaxo Group Ltd | Chemical compounds |
-
2001
- 2001-01-31 GB GBGB0102408.2A patent/GB0102408D0/en not_active Ceased
- 2001-12-17 BR BR0116854-1A patent/BR0116854A/pt not_active Application Discontinuation
- 2001-12-17 CA CA002434853A patent/CA2434853A1/en not_active Abandoned
- 2001-12-17 ES ES01994312T patent/ES2240557T3/es not_active Expired - Lifetime
- 2001-12-17 IL IL15663901A patent/IL156639A0/xx active IP Right Grant
- 2001-12-17 DE DE60110468T patent/DE60110468T2/de not_active Expired - Lifetime
- 2001-12-17 DK DK01994312T patent/DK1366033T3/da active
- 2001-12-17 NZ NZ526846A patent/NZ526846A/en unknown
- 2001-12-17 CZ CZ20032085A patent/CZ20032085A3/cs unknown
- 2001-12-17 KR KR10-2003-7010057A patent/KR20030070923A/ko not_active Application Discontinuation
- 2001-12-17 AT AT01994312T patent/ATE294167T1/de not_active IP Right Cessation
- 2001-12-17 PL PL01363359A patent/PL363359A1/xx not_active Application Discontinuation
- 2001-12-17 CN CNA018224415A patent/CN1487928A/zh active Pending
- 2001-12-17 AU AU2002246720A patent/AU2002246720B2/en not_active Ceased
- 2001-12-17 WO PCT/US2001/049299 patent/WO2002060885A1/en active IP Right Grant
- 2001-12-17 MX MXPA03006847A patent/MXPA03006847A/es active IP Right Grant
- 2001-12-17 PT PT01994312T patent/PT1366033E/pt unknown
- 2001-12-17 EP EP01994312A patent/EP1366033B1/en not_active Expired - Lifetime
- 2001-12-17 HU HU0303026A patent/HUP0303026A3/hu unknown
- 2001-12-17 JP JP2002561035A patent/JP2004521895A/ja active Pending
-
2003
- 2003-06-25 IL IL156639A patent/IL156639A/en not_active IP Right Cessation
- 2003-07-25 ZA ZA200305770A patent/ZA200305770B/en unknown
- 2003-07-30 NO NO20033401A patent/NO20033401L/no unknown
-
2004
- 2004-05-28 HK HK04103858A patent/HK1060883A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20032085A3 (cs) | 2003-12-17 |
| DK1366033T3 (da) | 2005-08-15 |
| IL156639A (en) | 2006-12-31 |
| BR0116854A (pt) | 2004-02-25 |
| PL363359A1 (en) | 2004-11-15 |
| GB0102408D0 (en) | 2001-03-14 |
| HUP0303026A3 (en) | 2007-06-28 |
| PT1366033E (pt) | 2005-08-31 |
| NO20033401L (no) | 2003-09-30 |
| EP1366033B1 (en) | 2005-04-27 |
| MXPA03006847A (es) | 2003-11-13 |
| ATE294167T1 (de) | 2005-05-15 |
| DE60110468T2 (de) | 2006-02-23 |
| WO2002060885A1 (en) | 2002-08-08 |
| CA2434853A1 (en) | 2002-08-08 |
| KR20030070923A (ko) | 2003-09-02 |
| AU2002246720B2 (en) | 2004-07-22 |
| ZA200305770B (en) | 2004-10-25 |
| DE60110468D1 (de) | 2005-06-02 |
| NO20033401D0 (no) | 2003-07-30 |
| EP1366033A1 (en) | 2003-12-03 |
| IL156639A0 (en) | 2004-01-04 |
| ES2240557T3 (es) | 2005-10-16 |
| JP2004521895A (ja) | 2004-07-22 |
| NZ526846A (en) | 2004-10-29 |
| CN1487928A (zh) | 2004-04-07 |
| HUP0303026A2 (hu) | 2003-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS20060320A (xx) | Supstituisani indazol-o-glukozidi | |
| MY142777A (en) | Substituted indole-o-glucosides | |
| HK1068335A1 (en) | Novel arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders | |
| UA86042C2 (xx) | Заміщені індазол-о-глюкозиди$замещенные индазол-о-глюкозиды | |
| BG108225A (en) | Thiohydantoins and use thereof for treating diabetes | |
| IL165257A0 (en) | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obestity anddyslipidemia | |
| TW200608961A (en) | Methods and reagents for the treatment of metabolic disorders | |
| AU2003299791A1 (en) | Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity | |
| AU2003281978A1 (en) | 2,5-diketopiperazines for the treatment of obesity | |
| MY135477A (en) | 2-(2,6-dichlorophenyl)-diarylimidazoles | |
| AU2002358390A1 (en) | Novel compounds | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| PL371127A1 (en) | 6-aminomorphinane derivatives, method for the production and use thereof | |
| NL1021504A1 (nl) | Waterstofbehandelingsproces. | |
| WO2005039626A3 (en) | Use of hydroxylated amino acids for treating diabetes | |
| DE50205466D1 (de) | Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen | |
| MXPA04000446A (es) | 4-aminociclohexanoles sustituidos. | |
| GB0102408D0 (en) | Chemical compounds | |
| AU2002231777A1 (en) | Use of mglur5 antagonists for the treatment of pruritic conditions | |
| MXPA04004090A (es) | Compuestos substituidos de 1h-quinolin-2-ona. | |
| MXPA05009428A (es) | Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas. | |
| EP1436279A4 (en) | CHEMICAL COMPOUNDS | |
| SE0202608D0 (sv) | New sequences | |
| SG153858A1 (en) | Regulators of bacterial signalling pathways | |
| ZA200308097B (en) | Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20091217 |